TCL Archive Phase II Imbruvica Trial Shows 47% of MCL Patients Alive at 27-Month Median Follow-up December 26, 2014
TCL Archive In Brief: Pursell Most Likely To Replace Conte, Foriend Of Cancer Program; DeVita Names Associate February 15, 1991
TCL Archive In Brief: Three, Perhaps Four May Be Recommended To Carter; Hugh Creech To Retire July 1 April 1, 1977